Mesenchymal cells in inflammation, immunity and cancer
Metadatos
Mostrar el registro completo del ítemEditorial
Springer Nature
Materia
Mesenchymal Cells Inflammation Immunity Fibrosis Cancer
Fecha
2020-08-03Referencia bibliográfica
Koliaraki, V., Prados, A., Armaka, M., & Kollias, G. (2020). The mesenchymal context in inflammation, immunity and cancer. Nature Immunology, 21(9), 974-982.
Patrocinador
FP7 Advanced ERC Grant MCs-inTEST (grant 340217)Resumen
Mesenchymal cells are mesoderm-derived stromal cells that are best known for providing
structural support to organs, synthesizing and remodeling the extracellular matrix (ECM) and
regulating development, homeostasis and repair of tissues. Recent detailed mechanistic
insights into the biology of fibroblastic mesenchymal cells have revealed they are also
significantly involved in immune regulation, stem cell maintenance and blood vessel function.
It is now becoming evident that these functions, when defective, drive the development of
complex diseases, such as various immunopathologies, chronic inflammatory disease, tissue
fibrosis and cancer. Here, we provide a concise overview of the contextual contribution of
fibroblastic mesenchymal cells in physiology and disease and bring into focus emerging
evidence for both their heterogeneity at the single-cell level and their tissue-specific,
spatiotemporal functional diversity.





